Get the Stockscreener App
64.09
0.17%
-0.11
After Hours:
64.09
Livanova Plc stock is traded at $64.09, with a volume of 416.14K.
It is down -0.17% in the last 24 hours and up +1.94% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$64.20
Open:
$64.2
24h Volume:
416.14K
Relative Volume:
0.71
Market Cap:
$3.50B
Revenue:
$1.28B
Net Income/Loss:
$-222.15M
P/E Ratio:
-15.67
EPS:
-4.09
Net Cash Flow:
$145.52M
1W Performance:
+1.86%
1M Performance:
+1.94%
6M Performance:
+46.76%
1Y Performance:
+29.40%
1-Day Range:
$63.66
$64.41
1-Week Range:
$62.45
$64.78
52-Week Range:
$32.48
$65.57
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
64.09 | 3.51B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
From Humanoid Robots to AI Seating: VivaNova Debuts "Active Health" Tech at imm cologne 2026 - GlobeNewswire Inc.
Understanding the Setup: (LIVN) and Scalable Risk - Stock Traders Daily
Autotransfusion System Market is expected to reach US$ 1,094.30 - openPR.com
Emerald Mutual Fund Advisers Trust Purchases 26,202 Shares of LivaNova PLC $LIVN - MarketBeat
Cardiac Pacemaker Market Covering Prime Factors - openPR.com
SG Americas Securities LLC Reduces Stake in LivaNova PLC $LIVN - MarketBeat
These 4 Measures Indicate That LivaNova (NASDAQ:LIVN) Is Using Debt Safely - 富途资讯
Extracorporeal Membrane Oxygenation (ECMO) Machines Market - openPR.com
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - marketscreener.com
About Us | Oil & Gas JournalLivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - FinancialContent
Should I buy LivaNova PLC (LIA) stock before earnings seasonEarnings Volatility Patterns & Small Investment Portfolio - bollywoodhelpline.com
Medical Implants Market Is Booming So Rapidly Growth by 2033 |Biotronik, Inc., Livanova Plc, NuVasive - openPR.com
Are Options Traders Betting on a Big Move in LivaNova Stock? - MSN
What risks investors should watch in LivaNova PLC stockEconomic Indicators Overview & Top Analyst Picks Available for Free - bollywoodhelpline.com
Wall Street Recap: Can LivaNova PLC maintain sales growth2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
LivaNova (NASDAQ:LIVN) Stock Price Crosses Above 50 Day Moving AverageTime to Sell? - MarketBeat
Aug Chart Watch: Whats the fair value of LivaNova PLC stock2025 Growth vs Value & Reliable Breakout Stock Forecasts - baoquankhu1.vn
LivaNova Announces Chief Legal Officer Resignation and Succession - The Globe and Mail
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins By Investing.com - Investing.com South Africa
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins - Investing.com UK
Does LivaNova PLC have strong fundamentalsEarnings Risk Report & Free Weekly Chart Analysis and Trade Guides - bollywoodhelpline.com
Market Trends: Does LivaNova PLC have pricing powerInsider Selling & Weekly Watchlist of Top Performers - baoquankhu1.vn
Macro Review: Is LivaNova PLC stock attractive for income investorsPortfolio Performance Summary & High Accuracy Investment Entry Signals - Bộ Nội Vụ
Extracorporeal Membrane Oxygenation Machine Market Size to Hit USD 725.99 Million by 2033, Growing at a CAGR of 4.91% - GlobeNewswire Inc.
LivaNova PLC (LIVN) Stock Analysis: Exploring a 17% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
The Technical Signals Behind (LIVN) That Institutions Follow - Stock Traders Daily
LivaNova (LIVN) Is Up 6.2% After Fresh Analyst Optimism on Advanced Therapies PortfolioWhat's Changed - Sahm
Is LivaNova PLC stock a dividend growth opportunityPortfolio Gains Report & Growth Oriented Trade Recommendations - Улправда
Neurological Implants Market to Reach USD 12.39 Billion by 2031 | - openPR.com
Barclays Raises Price Target for LivaNova (LIVN) Amidst Consistent Ratings | LIVN Stock News - GuruFocus
Will LivaNova PLC (LIA) stock outperform value peers2025 Fundamental Recap & Safe Entry Point Identification - ulpravda.ru
Is LivaNova PLC stock a top momentum playQuarterly Profit Summary & Expert Curated Trade Setups - Улправда
Published on: 2026-01-08 23:06:55 - Улправда
Published on: 2026-01-08 21:18:32 - Улправда
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 28%? - Yahoo Finance
The Brain: From Black Box To Engineering Problem - Seeking Alpha
Extracorporeal Membrane Oxygenation Machine Market - openPR.com
6 Analysts Assess LivaNova: What You Need To Know - Benzinga
Stifel raises Livanova stock price target to $70 on cardiopulmonary growth By Investing.com - Investing.com Canada
LIVN: Stifel Raises Price Target to $70, Maintains Buy Rating | - GuruFocus
LivaNova (NASDAQ:LIVN) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Stifel raises Livanova stock price target to $70 on cardiopulmonary growth - Investing.com Nigeria
In-Line Blood Monitoring Devices Market is expected to reach US$ - openPR.com
Market Fear: What is the fair value of LivaNova PLC stock nowTrade Risk Assessment & Fast Entry Momentum Alerts - moha.gov.vn
Electroceutical Devices Market to Reach USD 29,785.39 million - openPR.com
Published on: 2026-01-02 09:16:46 - moha.gov.vn
Precision Trading with Livanova Plc (LIVN) Risk Zones - Stock Traders Daily
LivaNova stock tests investor patience as Wall Street weighs turnaround against volatility - AD HOC NEWS
LivaNova CEO talks growth roadmap as company targets sleep apnea, depression therapies - MassDevice
LIVANOVA PLC (LIVN) - MSN
LivaNova PLC $LIVN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):